Log In
BCIQ
Print this Print this
 

Guardant 360, Guardant360

  Manage Alerts
Collapse Summary General Information
Company Guardant Health Inc.
DescriptionNon-invasive pan-cancer blood test
Molecular Target
Mechanism of Action 
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose tumor genetic alterations
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/21/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today